Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Oxcarbazepine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxcarbazepine 300mg tablets
0408010D0AAABAB
|
Oxcarbazepine | Oxcarbazepine | Central Nervous System | 16,672 |
|
Oxcarbazepine 150mg tablets
0408010D0AAACAC
|
Oxcarbazepine | Oxcarbazepine | Central Nervous System | 9,732 |
|
Oxcarbazepine 600mg tablets
0408010D0AAADAD
|
Oxcarbazepine | Oxcarbazepine | Central Nervous System | 7,092 |
|
Oxcarbazepine 60mg/ml oral suspension sugar free
0408010D0AAAEAE
|
Oxcarbazepine | Oxcarbazepine | Central Nervous System | 2,104 |
|
Oxcarbazepine 400mg/5ml oral suspension
0408010D0AAAFAF
|
Oxcarbazepine | Oxcarbazepine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.